| Patent | Date |
|---|
Biomarkers for CNS Disease Modification
App 20220146534 - Eisenbach-Schwartz; Michal ; et al. | 2022-05-12 |
Modified anti-PD-L1 Antibody and Methods and Uses for Treating a Neurodegenerative Disease
App 20210221893 - Yoles; Ester ; et al. | 2021-07-22 |
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Amyotrophic Lateral Sclerosis
App 20210221888 - Eisenbach-Schwartz; Michal ; et al. | 2021-07-22 |
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Amyotrophic Lateral Sclerosis
App 20210188977 - Eisenbach-Schwartz; Michal ; et al. | 2021-06-24 |
Modified anti-PD-L1 antibody and methods and uses for treating a neurodegenerative disease
Grant 10,995,141 - Yoles , et al. May 4, 2 | 2021-05-04 |
Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
Grant 10,981,989 - Eisenbach-Schwartz , et al. April 20, 2 | 2021-04-20 |
Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
Grant 10,961,309 - Eisenbach-Schwartz , et al. March 30, 2 | 2021-03-30 |
Modified anti-PD-L1 Antibody and Methods and Uses for Treating a Neurodegenerative Disease
App 20200332011 - Yoles; Ester ; et al. | 2020-10-22 |
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNS
App 20200140555 - Eisenbach-Schwartz; Michal ; et al. | 2020-05-07 |
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of a Retinal Degeneration Disorder
App 20200140553 - Eisenbach-Schwartz; Michal ; et al. | 2020-05-07 |
Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
Grant 10,618,963 - Eisenbach-Schwartz , et al. | 2020-04-14 |
Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
Grant 10,519,237 - Eisenbach-Schwartz , et al. Dec | 2019-12-31 |
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNS
App 20190185563 - Eisenbach-Schwartz; Michal ; et al. | 2019-06-20 |
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNS
App 20190112371 - Eisenbach-Schwartz; Michal ; et al. | 2019-04-18 |
Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
Grant 10,214,585 - Eisenbach-Schwartz , et al. Feb | 2019-02-26 |
Human monocyte sub-population for treatment of eye diseases and disorders
Grant 10,188,679 - Eisenbach-Schwartz , et al. Ja | 2019-01-29 |
Individualized Immunomodulation Therapy for Neurodegenerative Disorders, CNS Injury and Age-Related Dementia
App 20190022198 - Eisenbach-Schwartz; Michal ; et al. | 2019-01-24 |
Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
Grant 10,144,778 - Eisenbach-Schwartz , et al. De | 2018-12-04 |
Method And Vaccine Comprising Copolymer 1 For Treatment Of Psychiatric Disorders
App 20180207249 - EISENBACH-SCHWARTZ; Michal ; et al. | 2018-07-26 |
Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease
Grant 9,982,050 - Eisenbach-Schwartz , et al. May 29, 2 | 2018-05-29 |
Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease
Grant 9,982,049 - Eisenbach-Schwartz , et al. May 29, 2 | 2018-05-29 |
Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
Grant 9,982,047 - Eisenbach-Schwartz , et al. May 29, 2 | 2018-05-29 |
Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
Grant 9,982,051 - Eisenbach-Schwartz , et al. May 29, 2 | 2018-05-29 |
Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
Grant 9,982,048 - Eisenbach-Schwartz , et al. May 29, 2 | 2018-05-29 |
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease
App 20180118826 - Eisenbach-Schwartz; Michal ; et al. | 2018-05-03 |
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease
App 20180111998 - Eisenbach-Schwartz; Michal ; et al. | 2018-04-26 |
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNS
App 20180111999 - Eisenbach-Schwartz; Michal ; et al. | 2018-04-26 |
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease
App 20180111997 - Eisenbach-Schwartz; Michal ; et al. | 2018-04-26 |
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease
App 20180105592 - Eisenbach-Schwartz; Michal ; et al. | 2018-04-19 |
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNS
App 20180009893 - Eisenbach-Schwartz; Michal ; et al. | 2018-01-11 |
Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
Grant 9,856,318 - Eisenbach-Schwartz , et al. January 2, 2 | 2018-01-02 |
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNS
App 20170240634 - Eisenbach-Schwartz; Michal ; et al. | 2017-08-24 |
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNS
App 20170029508 - Eisenbach-Schwartz; Michal ; et al. | 2017-02-02 |
Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
Grant 9,534,052 - Eisenbach-Schwartz , et al. January 3, 2 | 2017-01-03 |
Vaccine and method for treatment of neurodegenerative diseases
Grant 9,517,256 - Eisenbach-Schwartz , et al. December 13, 2 | 2016-12-13 |
Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
Grant 9,512,227 - Eisenbach-Schwartz , et al. December 6, 2 | 2016-12-06 |
Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
Grant 9,512,225 - Eisenbach-Schwartz , et al. December 6, 2 | 2016-12-06 |
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease
App 20160319021 - Eisenbach-Schwartz; Michal ; et al. | 2016-11-03 |
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease
App 20160311905 - Eisenbach-Schwartz; Michal ; et al. | 2016-10-27 |
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease
App 20160297880 - Eisenbach-Schwartz; Michal ; et al. | 2016-10-13 |
Method And Vaccine Comprising Copolymer 1 For Treatment Of Psychiatric Disorders
App 20160213762 - EISENBACH-SCHWARTZ; Michal ; et al. | 2016-07-28 |
Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease
Grant 9,394,365 - Eisenbach-Schwartz , et al. July 19, 2 | 2016-07-19 |
Modified kisspeptin peptides and uses thereof
Grant 9,382,293 - Eisenbach-Schwartz , et al. July 5, 2 | 2016-07-05 |
Human Monocyte Sub-Population for Treatment of Eye Diseases and Disorders
App 20160166612 - EISENBACH-SCHWARTZ; Michal ; et al. | 2016-06-16 |
Human monocyte sub-population for treatment of central nervous system injury
Grant 9,314,483 - Eisenbach-Schwartz , et al. April 19, 2 | 2016-04-19 |
Reducing Systemic Regulatory T Cell Levels Or Activity For Treatment Of Disease And Injury Of The Cns
App 20160008463 - EISENBACH-SCHWARTZ; Michal ; et al. | 2016-01-14 |
Reducing Systemic Regulatory T Cell Levels Or Activity For Treatment Of Disease And Injury Of The Cns
App 20160000909 - EISENBACH-SCHWARTZ; Michal ; et al. | 2016-01-07 |
Individualized Immunomodulation Therapy For Neurodegenerative Disorders, Cns Injury And Age-related Dementia
App 20150238582 - Eisenbach-Schwartz; Michal ; et al. | 2015-08-27 |
Cellular Blood Markers For Early Diagnosis Of Als And For Als Progression
App 20150209404 - EISENBACH-SCHWARTZ; Michal ; et al. | 2015-07-30 |
Method of treatment of age-related macular degeneration
Grant 9,089,509 - Eisenbach-Schwartz , et al. July 28, 2 | 2015-07-28 |
Cellular Markers For Diagnosis Of Alzheimer's Disease And For Alzheimer's Disease Progression
App 20150057176 - Eisenbach-Schwartz; Michal ; et al. | 2015-02-26 |
Modified Kisspeptin Peptides and Uses Thereof
App 20150051151 - Eisenbach-Schwartz; Michal ; et al. | 2015-02-19 |
Human Monocyte Sub-population For Treatment Of Central Nervous System Injury
App 20140363411 - Eisenbach-Schwartz; Michal ; et al. | 2014-12-11 |
Eye-drop vaccine containing copolymer 1 for therapeutic immunization
Grant 8,895,501 - Eisenbach-Schwartz , et al. November 25, 2 | 2014-11-25 |
Vaccine and method for treatment of neurodegenerative diseases
Grant 8,828,404 - Eisenbach-Schwartz , et al. September 9, 2 | 2014-09-09 |
Vaccine And Method For Treatment Of Neurodegenerative Diseases
App 20140134196 - EISENBACH-SCHWARTZ; Michal ; et al. | 2014-05-15 |
GPR54 agonists or antagonists for treatment of diseases presenting behavioral abnormalities
Grant 8,716,228 - Eisenbach-Schwartz , et al. May 6, 2 | 2014-05-06 |
Cellular Blood Markers For Early Diagnosis Of Als And For Als Progression
App 20130230499 - Eisenbach-Schwartz; Michal ; et al. | 2013-09-05 |
Process for the manufacturing of human mononuclear phagocytic leukocytes
Grant 8,377,692 - Fulga , et al. February 19, 2 | 2013-02-19 |
Induction Of Neurogenesis And Stem Cell Therapy In Combination With Copolymer 1
App 20120135016 - Eisenbach-Schwartz; Michal ; et al. | 2012-05-31 |
Gpr54 Agonists Or Antagonists For Treatment Of Diseases Presenting Behavioral Abnormalities
App 20120135935 - Eisenbach-Schwartz; Michal ; et al. | 2012-05-31 |
Vaccine And Method For Treatment Of Neurodegenerative Diseases
App 20110206706 - Eisenbach-Schwartz; Michal ; et al. | 2011-08-25 |
Method and vaccine comprising copolymer 1 for treatment of psychiatric disorders
App 20110117115 - Eisenbach-Schwartz; Michal ; et al. | 2011-05-19 |
Agents And Methods For Treatment Of Anxiety Disorders
App 20110033488 - Eisenbach-Schwartz; Michal ; et al. | 2011-02-10 |
Dopamine and agonists and antagonists thereof for modulation of suppressive activity of CD4+CD25+ regulatory T cells
App 20100168085 - Eisenbach-Schwartz; Michal ; et al. | 2010-07-01 |
Method of treatment of age-related macular degeneration
App 20100135953 - Eisenbach-Schwartz; Michal ; et al. | 2010-06-03 |
Eye-drop Vaccine Containing Copolymer 1 For Therapeutic Immunization
App 20090214470 - EISENBACH-SCHWARTZ; MICHAL ; et al. | 2009-08-27 |
Induction Of Neurogenesis And Stem Cell Therapy In Combination With Copolymer 1
App 20090191173 - Eisenbach-Schwartz; Michal ; et al. | 2009-07-30 |
Method for reducing neuronal degeneration so as to ameliorate the effects of injury or disease
Grant 7,560,102 - Eisenbach-Schwartz , et al. July 14, 2 | 2009-07-14 |
Methods of Cell Therapy, Neurogenesis and Oligodendrogenesis
App 20090010873 - Eisenbach-Schwartz; Michal ; et al. | 2009-01-08 |
Method For Reducing Neuronal Degeneration By Administering Cns-derived Peptides Or Activated T Cells
App 20080279869 - Eisenbach-Schwartz; Michal ; et al. | 2008-11-13 |
Use of copolymer 1 and related peptides and polypeptides and T cells treated herewith for neuroprotective glaucoma therapy
Grant 7,407,936 - Eisenbach-Schwartz , et al. August 5, 2 | 2008-08-05 |
Poly-Glu,Tyr for neuroprotective therapy
Grant 7,399,740 - Eisenbach-Schwartz , et al. July 15, 2 | 2008-07-15 |
Vaccine And Method For Treatment Of Neurodegenerative Diseases
App 20080085269 - Eisenbach-Schwartz; Michal ; et al. | 2008-04-10 |
Method for neuronal protection in amyotrophic lateral sclerosis by a vaccine comprising Copolymer-1 or Copolymer-1 related peptides
Grant 7,351,686 - Eisenbach-Schwartz , et al. April 1, 2 | 2008-04-01 |
Eye-Drop Vaccine Containing Copolymer 1 for Therapeutic Immunization
App 20070248569 - Eisenbach-Schwartz; Michal ; et al. | 2007-10-25 |
Method for Treating or Inhibiting the Effects of Injuries or Diseases that Result in Neuronal Degeneration
App 20070225251 - Eisenbach-Schwartz; Michal ; et al. | 2007-09-27 |
Antigen-presenting cells for neuroprotection and nerve regeneration
App 20060057110 - Eisenbach-Schwartz; Michal ; et al. | 2006-03-16 |
Use of an organ-specific self-pathogen for treatment of a non-autoimmune disease of said organ
App 20050220803 - Eisenbach-Schwartz, Michal ; et al. | 2005-10-06 |
Vaccine and method for treatment of motor neurone diseases
App 20050220802 - Eisenbach-Schwartz, Michal ; et al. | 2005-10-06 |
Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy
App 20050159336 - Eisenbach-Schwartz, Michal ; et al. | 2005-07-21 |
Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy
Grant 6,844,314 - Eisenbach-Schwartz , et al. January 18, 2 | 2005-01-18 |
Use of poly-Glu,Tyr for neuroprotective therapy
Grant 6,835,711 - Eisenbach-Schwartz , et al. December 28, 2 | 2004-12-28 |
Method for reducing neuronal degeneration so as to ameliorate the effects of injury or disease
App 20040253218 - Eisenbach-Schwartz, Michal ; et al. | 2004-12-16 |
Poly-Glu, Tyr for neuroprotective therapy
App 20040248802 - Eisenbach-Schwartz, Michal ; et al. | 2004-12-09 |
Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration
App 20040192588 - Eisenbach-Schwartz, Michal ; et al. | 2004-09-30 |
Central nervous system-derived immune privilege factor and uses thereof
App 20040142860 - Eisenbach-Schwartz, Michal ; et al. | 2004-07-22 |
Activated T-cells, Nervous System-specific Antigens And Their Uses
App 20030108528 - EISENBACH-SCHWARTZ, MICHAL ; et al. | 2003-06-12 |
Use of poly-Glu,Tyr and T cells treated therewith for neuroprotective therapy
App 20030003082 - Eisenbach-Schwartz, Michal ; et al. | 2003-01-02 |
Activated T cells, nervous system-specific antigens and their uses
App 20020072493 - Eisenbach-Schwartz, Michal ; et al. | 2002-06-13 |
Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy
App 20020037848 - Eisenbach-Schwartz, Michal ; et al. | 2002-03-28 |
Anti-inflammatory dipeptide and pharmaceutical composition thereof
Grant 6,126,939 - Eisenbach-Schwartz , et al. October 3, 2 | 2000-10-03 |
| 